Lea Hoisnard (Léa Hoisnard)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Topics

Rheumatoid Arthritis

Top Venues

Arthritis & rheumatology (Hoboken, N.J.)

BMJ (Clinical research ed.)

European journal of neurology

Annals of the rheumatic diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Noemie Roland, Anke Neumann, Lea Hoisnard, Lise Duranteau, Sébastien Froelich, Mahmoud Zureik, Alain Weill
Use of progestogens and the risk of intracranial meningioma: national case-control study. BMJ (Clinical research ed.) 384 (2024)
Lea Hoisnard, Antoine Meyer, Rosemary Dray-Spira, Alain Weill, Mahmoud Zureik, Emilie Sbidian
Risk of Gastrointestinal Perforation in Patients With Rheumatic Diseases Exposed to Janus Kinase Inhibitors Versus Adalimumab: A Nationwide Cohort Study. Arthritis & rheumatology (Hoboken, N.J.) 76 (9) (2024)
Lea Hoisnard, Antoine Meyer, Rosemary Dray-Spira, Alain Weill, Mahmoud Zureik, Emilie Sbidian
Risk of Gastrointestinal Perforation in Patients With Rheumatic Diseases Exposed to Janus Kinase Inhibitors Versus Adalimumab: A Nationwide Cohort Study. Arthritis & rheumatology (Hoboken, N.J.) (2024)
Noemie Roland, Anke Neumann, Lea Hoisnard, Lise Duranteau, Sébastien Froelich, Mahmoud Zureik, Alain Weill
Use of progestogens and the risk of intracranial meningioma: national case-control study. BMJ (Clinical research ed.) 384 (2024)
Noemie Roland, Anke Neumann, Lea Hoisnard, Lise Duranteau, Sébastien Froelich, Mahmoud Zureik, Alain Weill
Use of progestogens and the risk of intracranial meningioma: national case-control study. BMJ (Clinical research ed.) 384 (2024)
Lea Hoisnard, Antoine Meyer, Rosemary Dray-Spira, Alain Weill, Mahmoud Zureik, Emilie Sbidian
Risk of Gastrointestinal Perforation in Patients With Rheumatic Diseases Exposed to Janus Kinase Inhibitors Versus Adalimumab: A Nationwide Cohort Study. Arthritis & rheumatology (Hoboken, N.J.) 76 (9) (2024)
Lea Hoisnard, Antoine Meyer, Rosemary Dray-Spira, Alain Weill, Mahmoud Zureik, Emilie Sbidian
Risk of gastrointestinal perforation in patients with rheumatic diseases exposed to janus kinase inhibitors versus adalimumab: nationwide cohort study. Arthritis & rheumatology (Hoboken, N.J.) (2024)
Hugo Jourdain, Lea Hoisnard, Emilie Sbidian, Mahmoud Zureik
Severe Hypersensitivity Reactions at Biosimilar versus Originator Rituximab Treatment Initiation, Switch and Over Time: A Cohort Study on the French National Health Data System. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2023)
Lea Hoisnard, Moussa Laanani, Thibault Passeri, Lise Duranteau, Joël Coste, Mahmoud Zureik, Sébastien Froelich, Alain Weill
Risk of intracranial meningioma with three potent progestogens: A population-based case-control study. European journal of neurology 29 (9) (2022)
Lea Hoisnard, Laura Pina Vegas, Rosemay Dray-Spira, Alain Weill, Mahmoud Zureik, Emilie Sbidian
Risk of major adverse cardiovascular and venous thromboembolism events in patients with rheumatoid arthritis exposed to JAK inhibitors versus adalimumab: a nationwide cohort study. Annals of the rheumatic diseases (2022)